Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 58.85
-0.65 (-1.09%)
May 28, 2026, 10:20 AM HKT
47.31% (1Y)
| Market Cap | 17.53B +36.8% |
| Revenue (ttm) | 797.12M +67.3% |
| Net Income | -581.60M |
| EPS | -2.12 |
| Shares Out | 294.60M |
| PE Ratio | n/a |
| Forward PE | 24.66 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 313,000 |
| Open | 60.00 |
| Previous Close | 59.50 |
| Day's Range | 58.20 - 60.10 |
| 52-Week Range | 39.50 - 81.85 |
| Beta | -0.11 |
| Analysts | Strong Buy |
| Price Target | 93.06 (+58.13%) |
| Earnings Date | Mar 26, 2026 |